Medication leaflets

Active substance

Results for the substance polysaccharide conjugate pneumococcal vaccine

5 results

About this active substance

The pneumococcal conjugate vaccine (PCV13) is used to prevent infections caused by Streptococcus pneumoniae, including pneumonia, meningitis, and otitis media. The vaccine contains capsular polysaccharides from 13 different serotypes of the bacterium, linked to a carrier protein, which stimulates a stronger and longer-lasting immune response.

The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for children, adults, and individuals at increased risk of pneumococcal infections.

Common side effects include pain at the injection site, mild fever, irritability, and fatigue. In rare cases, severe allergic reactions may occur.

The pneumococcal conjugate vaccine is an essential measure for protecting against pneumococcal infections, particularly among young children and vulnerable individuals, helping to reduce the morbidity and mortality associated with these infections.